Publications

122"Identification of Lactate Dehydrogenase 5 Inhibitors using Pharmacophore- Driven Consensus Docking." Poli G, Scarpino A, Aissaoui M, Granchi C, Minutolo F, Martinelli, Tuccinardi T. Curr Bioact Comp. 2018, ASAP.
Link to Journal
121"Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer." Spena CR, De Stefano L, Palazzolo S, Salis B, Granchi C, Minutolo F, Tuccinardi T, Fratamico R, Crotti S, D'Aronco S, Agostini M, Corona G, Caligiuri I, Canzonieri V, Rizzolio F. J Control Release. 2018, ASAP
Link to Journal
120"Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors." Poli G, Lapillo M, Granchi C, Caciolla J, Mouawad N, Caligiuri I, Rizzolio F, Langer T, Minutolo F, Tuccinardi T. J Enzyme Inhib Med Chem. 2018, 33(1):956-961.
Link to Journal
119"Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors." Aghazadeh Tabrizi M, Baraldi PG, Baraldi S, Ruggiero E, De Stefano L, Rizzolio F, Di Cesare Mannelli L, Ghelardini C, Chicca A, Lapillo M, Gertsch J, Manera C, Macchia M, Martinelli A, Granchi C, Minutolo F, Tuccinardi T. J Med Chem. 2018, 61(3):1340-1354.
Link to Journal
118"Heterocyclic periphery in the design of carbonic anhydrase inhibitors: 1,2,4-Oxadiazol-5-yl benzenesulfonamides as potent and selective inhibitors of cytosolic hCA II and membrane-bound hCA IX isoforms." Krasavin M, Shetnev A, Sharonova T, Baykov S, Tuccinardi T, Kalinin S, Angeli A, Supuran CT. Bioorg Chem. 2018, 76:88-97.
Link to Journal
117"Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors." Poli G, Granchi C, Aissaoui M, Minutolo F, Tuccinardi T. Molecules. 2017, 22(12):2217.
Link to Journal
116"A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)." Granchi C, Caligiuri I, Minutolo F, Rizzolio F, Tuccinardi T. Expert Opin Ther Pat. 2017, 27(12):1341-1351.
Link to Journal
115"Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors." Granchi C, Caligiuri I, Bertelli E, Poli G, Rizzolio F, Macchia M, Martinelli A, Minutolo F, Tuccinardi T. J Enzyme Inhib Med Chem. 2017, 32(1):1240-1252.
Link to Journal
114"Lucky switcheroo: dramatic potency and selectivity improvement of imidazoline inhibitors of human carbonic anhydrase VII." Kalinin S, Kopylov S, Tuccinardi T, Sapegin A, Darin D, Angeli A, Supuran CT, Krasavin M. ACS Med Chem Lett. 2017, 8(10):1105-1109.
Link to Journal
113"Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases." Krasavin M, Korsakov M, Ronzhina O, Tuccinardi T, Kalinin S, Tanç M, Supuran CT. J Enzyme Inhib Med Chem. 2017, 32(1):920-934.
Link to Journal
112"Constituents of Polygala flavescens ssp. flavescens and Their Activity as Inhibitors of Human Lactate Dehydrogenase." De Leo M, Peruzzi L, Granchi C, Tuccinardi T, Minutolo F, De Tommasi N, Braca A. J Nat Prod. 2017, 80(7):2077-2087.
Link to Journal
111"Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer." Granchi C, Fortunato S, Meini S, Rizzolio F, Caligiuri I, Tuccinardi T, Lee HY, Hergenrother PJ, Minutolo F. J Agric Food Chem. 2017, 65(28):5639-5649.
Link to Journal
110"Bifunctional Inhibitors as a new tool to reduce cancer cell invasion by impairing MMP-9 homodimerization." Nuti E, Rosalia L, Cuffaro D, Camodeca C, Giacomelli C, Da Pozzo E, Tuccinardi T, Costa C, Antoni C, Vera L, Ciccone L, Orlandini E, Nencetti E, Dive V, Martini C, Stura EA, Rossello A. ACS Med Chem Lett. 2017, 8(3):293-298.
Link to Journal
109"Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3- and 4-(hetero)arylisoxazol-5-amine scaffolds." Krasavin M, Korsakov M, Zvonaryova Z, Semyonychev E, Tuccinardi T, Kalinin S, Tanç M, Supuran CT. Bioorg. Med. Chem. 2017, 25(6):1914-1925.
Link to Journal
108"Antibacterial and Hypoglycemic Diterpenoids from Salvia chamaedryoides." Bisio A, De Mieri M, Milella L, Schito AM, Parricchi A, Russo D, Alfei S, Lapillo M, Tuccinardi T, Hamburger M, De Tommasi N. J. Nat. Prod. 2017, 80(2):503-514.
Link to Journal
107"Immunomodulatory Properties of 1,2-Dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide Derivative VL15." Malfitano AM, Laezza C, Bertini S, Marasco D, Tuccinardi T, Bifulco M, Manera C. Biochimie. 2017, 135:173-180.
Link to Journal
106"Bottom-Up Synthesis of Carbon Nanoparticles with Higher Doxorubicin Efficacy." Bayda S, Hadla M, Palazzolo S, Kumar V, Caligiuri I, Ambrosi E, Pontoglio E, Agostini M, Tuccinardi T, Benedetti A, Riello P, Canzonieri V, Corona G, Toffoli G, Rizzolio F. J Contr. Rel. 2017, 248:144-152.
Link to Journal
105"Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies." Poli G, Martinelli Tuccinardi T. J Enzyme Inhib Med Chem. 2016, 31(sup2):167-173.
Link to Journal
104"Structural optimization of 4-chlorobenzoylpiperidine derivatives for the development of potent, reversible and selective monoacylglycerol lipase (MAGL) inhibitors." Granchi C, Rizzolio F, Palazzolo S, Carmignani S, Macchia M, Saccomanni G, Manera C, Martinelli A, Minutolo F, Tuccinardi T. J Med Chem. 2016, 59(22):10299-10314.
Link to Journal
103"Drug affinity responsive target stability (DARTS) identifies laurifolioside as a new clathrin heavy chain modulator." Dal Piaz F, Saltos MBV, Franceschelli S, Forte G, Marzocco S, Tuccinardi T, Poli G, Ebrahimi SN, Hamburger M, De Tommasi N, Braca A. J Nat Prod. 2016, 79(10):2681-2692.
Link to Journal
102"Human carbonyl reductase 1 as efficient catalyst for the reduction of glutathionylated aldehydes derived from lipid peroxidation." Rotondo R, Moschini R, Renzone G, Tuccinardi T, Balestri F, Cappiello M, Scaloni A, Mura U, Del-Corso A. Free Radic Biol Med. 2016, 99:323-332.
Link to Journal
101"α-Glucosidase and α-Amylase Inhibitors from Arcytophyllum thymifolium." Milella L, Milazzo S, De Leo M, Vera Saltos M, Faraone I, Tuccinardi T, Lapillo M, De Tommasi N, Braca A. J Nat Prod. 2016, 79(8):2104-12.
Link to Journal
100"Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds." Petrou A, Geronikaki A, Terzi E, Ozensoy Guler O, Tuccinardi T, Supuran CT. J Enzyme Inhib Med Chem. 2016, 31(6):1306-1311.
Link to Journal
99"A Virtual Screening Study for Lactate Dehydrogenase 5 Inhibitors by using a Pharmacophore-Based Approach." Tuccinardi T, Poli G, Corchia I, Granchi C, Lapillo M, Macchia M, Minutolo F, Ortore G, Martinelli A. Molecular Inf. 2016, 35(8-9):434-439.
Link to Journal
98"Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach." Poli G, Gelain A, Porta F, Asai A, Martinelli A, Tuccinardi T. J Enzyme Inhib Med Chem. 2016, 31(6):1011-1017.
Link to Journal
97"Cyclic Ketoximes as Estrogen Receptor β Selective Agonists." Granchi C, Lapillo M, Spena CR, Rizzolio F, Tuccinardi T, Martin TA, Carlson KE, Katzenellenbogen JA, Minutolo F. ChemMedChem. 2016, 11(16):1752-61.
Link to Journal
96"Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII." Kumar S, Ceruso M, Tuccinardi T, Supuran CT, Sharma PK. Bioorg Med Chem. 2016, 24(13):2907-29013.
Link to Journal
95"Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists." Tabrizi MA, Baraldi PG, Ruggiero E, Saponaro G, Baraldi S, Poli G, Tuccinardi T, Ravani A, Vincenzi F, Borea PA, Varani K. Eur J Med Chem. 2016, 113:11-27.
Link to Journal
94"Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin’s lymphoma cell models." Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A. Eur J Med Chem. 2016, 111:193-201.
Link to Journal
93"4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors." Granchi C, Rizzolio F, Bordoni V, Caligiuri I, Manera C, Macchia M, Minutolo F, Martinelli A, Giordano A, Tuccinardi T. J Enzyme Inhib Med Chem. 2016 31(1):137-146.
Link to Journal
92"Salicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer Cells." Granchi C, Qian Y, Yeon Lee H, Paterni I, Pasero C, Iegre J, Carlson KE, Tuccinardi T, Chen X, Katzenellenbogen JA, Hergenrother PJ, Minutolo FM. ChemMedChem. 2015, 10(11):1892-1900.
Link to Journal
91"N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in vivo Antiangiogenic Activity." Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A. J Med Chem. 2015, 58(18):7224-7240.
Link to Journal
90Probing the ‘bipolar’ nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms." Krasavin M, Korsakov M, Dorogov M, Tuccinardi T, Dedeoglu N, Supuran CT. Eur J Med Chem. 2015, 101:334-347.
Link to Journal
89"Receptor-based virtual screening evaluation for the identification of estrogen receptor β ligands." Tuccinardi T, Poli G, dell’Agnello M, Granchi C, Minutolo F, Martinelli A. J Enzyme Inhib Med Chem. 2015, 30(4):662-670.
Link to Journal
88"The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives." Nassini R, Fusi C, Materazzi S, Coppi E, Tuccinardi T, Marone IM, De Logu F, Preti D, Tonello R, Chiarugi A, Patacchini R, Geppetti P, Benemei S. Br J Pharmacol. 2015, 172(13):3397-3411.
Link to Journal
87"Studies on the ATP binding site of Fyn kinase for the identification of new inhibitors and their evaluation as potential agents against tauopathies and tumors." Tintori C, La Sala G, Vignaroli G, Botta L, Fallacara AL, Falchi F, Radi M, Zamperini C, Dreassi E, Dello Iacono L, Orioli D, Biamonti G, Garbelli M, Lossani A, Gasparrini F, Tuccinardi T, Laurenzana I, Angelucci A, Maga G, Schenone S, Brullo C, Musumeci F, Desogus A, Crespan E, Botta M. J Med Chem. 2015 58(11):4590-4609.
Link to Journal
86"Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH)." Tabrizi MA, Baraldi PG, Ruggiero E, Saponaro G, Baraldi S, Romagnoli R, Martinelli A, Tuccinardi T. Eur J Med Chem. 2015, 97:289-305.
Link to Journal
85"Phenylpropanoids and Flavonoids from Phlomis kurdica as Inhibitors of Human Lactate Dehydrogenase." Bader A, Tuccinardi T, Granchi C, Martinelli A, Macchia M, Minutolo F, De Tommasi N, Braca A. Phytochem. 2015, 116:262-268.
Link to Journal
84"Development and Validation of a Docking-Based Virtual Screening Platform for the Identification of New Lactate Dehydrogenase Inhibitors" Granchi C, Capecchi A, Del Frate G, Martinelli A, Macchia M, Minutolo F, Tuccinardi T. Molecules. 2015, 20(5):8772-8790.
Link to Journal
83"Application of a FLAP-Consensus Docking Mixed Strategy for the Identification of New FAAH Inhibitors" Poli G, Giuntini N, Martinelli A, Tuccinardi T. J Chem Inf Model. 2015, 55(3):667-675.
Link to Journal
82"Synthesis and biological evaluation of non-glucose glycoconjugated N-hydroyxindole class LDH inhibitors as anticancer agents." Di BussoloV, Calvaresi EC, Granchi C, Del Bino L, Frau I, Dasso Lang MC, Tuccinardi T, Macchia M, Martinelli A, Hergenrother PJ, Minutolo F. RSC Adv. 2015, 5(26):19944-19954.
Link to Journal
81"Highly selective salicylketoxime-based estrogen receptor beta agonists display antiproliferative activities in a glioma model." Paterni I, Bertini S, Granchi C, Tuccinardi T, Macchia M, Martinelli A, Caligiuri I, Toffoli G, Rizzolio F, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Minutolo F. J Med Chem. 2015, 58(3):1184–1194.
Link to Journal
80"Interaction of the anticancer gallium(III) complexes of 8-hydroxyquinoline and maltol with human serum proteins." Enyedy EA, Dömötör O, Bali K, Hetényi A, Tuccinardi T, Keppler BK. J Biol Inorg Chem. 2015, 20(1):77-88
Link to Journal

79"Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1." Fusi C, Materazzi S, Benemei S, Coppi E, Trevisan G, Marone I, Minocci D, De Logu F, Tuccinardi T, Di Tommaso M, Susini T, Moneti G, Pieraccini G, Geppetti P, Nassini R. Nature Communications 2014 , 5:5736. Link to Journal
78"Extensive Consensus Docking Evaluation for Ligand Pose Prediction and Virtual Screening Studies." Tuccinardi T, Poli G, Romboli V, Giordano A, Martinelli A. J Chem Inf Model. 2014, 54(10):2980-2986.
Link to Journal
77"Computational approaches for the identification and optimization of SRC family kinases inhibitors." Poli G, Martinelli A, Tuccinardi T. Curr Med Chem. 2014, 21(28):3281-3293.
Link to Journal
76"Identification and characterization of a new reversible MAGL inhibitor." Tuccinardi T, Granchi C, Rizzolio F, Caligiuri I, Battistello V, Toffoli G, Minutolo F, Macchia M, Martinelli A. Bioorg Med Chem. 2014, 22(13):3285-3291.
Link to Journal
75"Targeting Toxic RNAs that Cause Myotonic Dystrophy Type 1 (DM1) with a Bisamidinium Inhibitor." Wong CH, Nguyen L, Peh J, Luu LM, Sanchez JS, Richardson SL, Tuccinardi T, Tsoi H, Chan WY, Chan HY, Baranger AM, Hergenrother PJ, Zimmerman SC. J Am Chem Soc. 2014, 136(17):6355-6361.
Link to Journal
74"Study of the binding interaction between fluorinated matrix metalloproteinase inhibitors and Human Serum Albumin." Digilio G, Tuccinardi T, Casalini F, Cassino C, Dias DM, Geraldes CF, Catanzaro V, Maiocchi A, Rossello A. Eur J Med Chem. 2014 2014, 79:13-23
Link to Journal
73"Interaction of anticancer reduced Schiff base coumarin derivatives with human serum albumin investigated by fluorescence quenching and molecular modeling." Dömötör O, Tuccinardi T, Karcz D, Walsh M, Creaven BS, Enyedy EA. Bioorg Chem. 2014, 52:16-23.
Link to Journal
72"Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells." Tuccinardi T, Granchi C, Iegre J, Paterni I, Bertini S, Macchia M, Martinelli A, Qian Y, Chen X, Minutolo F. Bioorg Med Chem Lett. 2013, 23(24):6923-7.
Link to Journal
71"Dual targeting of the warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor." Calvaresi EC, Granchi C, Tuccinardi T, Di Bussolo V, Huigens RW 3rd, Lee HY, Palchaudhuri R, Macchia M, Martinelli A, Minutolo F, Hergenrother PJ. Chembiochem. 2013, 14(17):2263-7.
Link to Journal
70"Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives." Malfitano AM, Laezza C, Saccomanni G, Tuccinardi T, Manera C, Martinelli A, Ciaglia E, Pisanti S, Vitale M, Gazzerro P, Bifulco M. J Neuroimmune Pharmacol. 2013, 8(5):1077-86.
Link to Journal
69"Identification of new FYN kinase inhibitors using a FLAP-based approach." Poli G, Tuccinardi T, Rizzolio F, Caligiuri I, Botta L, Granchi C, Ortore G, Minutolo F, Schenone S, Martinelli A. J Chem Inf Model. 2013, 53(10):2538-47.
Link to Journal
68"Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds." Granchi C, Calvaresi EC, Tuccinardi T, Paterni I, Macchia M, Martinelli A, Hergenrother PJ, Minutolo F. Org Biomol Chem. 2013 ,11(38):6588-96.
Link to Journal
67"Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists." Aghazadeh Tabrizi M, Baraldi PG, Saponaro G, Moorman AR, Romagnoli R, Preti D, Baraldi S, Ruggiero E, Tintori C, Tuccinardi T, Vincenzi F, Borea PA, Varani K. J Med Chem. 2013, 56(11):4482-96.
Link to Journal
66"Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis." Malfitano AM, Laezza C, D'Alessandro A, Procaccini C, Saccomanni G, Tuccinardi T, Manera C, Macchia M, Matarese G, Gazzerro P, Bifulco M. PLoS One. 2013, 8(5):e62511.
Link to the Journal
65"Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors." Tuccinardi T, Bertini S, Granchi C, Ortore G, Macchia M, Minutolo F, Martinelli A, Supuran CT. Bioorg Med Chem. 2013, 21(6):1511-5.
Link to the Journal
64"Investigating the binding mode of an inhibitor of the MBNL1·RNA complex in myotonic dystrophy type 1 (DM1) leads to the unexpected discovery of a DNA-selective binder." Wong CH, Richardson SL, Ho YJ, Lucas AM, Tuccinardi T, Baranger AM, Zimmerman SC. Chembiochem. 2012, 13(17):2505-9.
Link to Journal
63"Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold." Manera C, Saccomanni G, Malfitano AM, Bertini S, Castelli F, Laezza C, Ligresti A, Lucchesi V, Tuccinardi T, Rizzolio F, Bifulco M, Di Marzo V, Giordano A, Macchia M, Martinelli A. Eur J Med Chem. 2012, 52:284-94.
Link the Journal
62"Computational studies on translocator protein (TSPO) and its ligands." Ortore G, Tuccinardi T, Martinelli A. Curr Top Med Chem. 2012, 12(4):352-9.
Link to the Journal
61"Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5." Granchi C, Roy S, Mottinelli M, Nardini E, Campinoti F, Tuccinardi T, Lanza M, Betti L, Giannaccini G, Lucacchini A, Martinelli A, Macchia M, Minutolo F.
Bioorg Med Chem Lett. 2011, 21(24):7331-6.
Link to the Journal
60"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases." Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA. J Med Chem. 2011, 54(24):8289-98.
Link to the Journal
59"N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation." Granchi C, Roy S, De Simone A, Salvetti I, Tuccinardi T, Martinelli A, Macchia M, Lanza M, Betti L, Giannaccini G, Lucacchini A, Giovannetti E, Sciarrillo R, Peters GJ, Minutolo F. Eur J Med Chem. 2011, 46(11):5398-407.
Link to the Journal
58"Interactions of the carrier ligands of antidiabetic metal complexes with human serum albumin: a combined spectroscopic and separation approach with molecular modeling studies." Enyedy EA, Horváth L, Hetényi A, Tuccinardi T, Hartinger CG, Keppler BK, Kiss T. Bioorg Med Chem. 2011, 19(14):4202-10.
Link to the Journal
57"Protein kinase homology models: recent developments and results." Tuccinardi T, Martinelli A. Curr Med Chem. 2011, 18(19):2848-53.
Link to the Journal
56"Novel folate-hydroxamate based antimetabolites: synthesis and biological evaluation." Carrasco MP, Enyedy EA, Krupenko NI, Krupenko SA, Nuti E, Tuccinardi T, Santamaria S, Rossello A, Martinelli A, Santos MA. Med Chem. 2011 , 7(4):265-74.
Link to the Journal
55"Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes." Bertini S, De Cupertinis A, Granchi C, Bargagli B, Tuccinardi T, Martinelli A, Macchia M, Gunther JR, Carlson KE, Katzenellenbogen JA, Minutolo F. Eur J Med Chem. 2011, 46(6):2453-62.
Link to the Journal
54"Binding-interaction prediction of RNA-binding ligands." Tuccinardi T. Future Med Chem. 2011, 3(6):723-33.
Link to the Journal
53"Substituted pyrazolo[3,4-b]pyridines as human A1 adenosine antagonists: developments in understanding the receptor stereoselectivity." Tuccinardi T, Zizzari AT, Brullo C, Daniele S, Musumeci F, Schenone S, Trincavelli ML, Martini C, Martinelli A, Giorgi G, Botta M. Org Biomol Chem. 2011, 9(12):4448-55.
Link to the Journal
52"Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells." Granchi C, Roy S, Giacomelli C, Macchia M, Tuccinardi T, Martinelli A, Lanza M, Betti L, Giannaccini G, Lucacchini A, Funel N, León LG, Giovannetti E, Peters GJ, Palchaudhuri R, Calvaresi EC, Hergenrother PJ, Minutolo F. J Med Chem. 2011, 54(6):1599-612.
Link to the Journal
51"Different binding modes of structurally diverse ligands for human D3DAR." Ortore G, Tuccinardi T, Orlandini E, Martinelli A. J Chem Inf Model. 2010, 50(12):2162-75.
Link to the Journal
50"Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties." Bertini S, Calderone V, Carboni I, Maffei R, Martelli A, Martinelli A, Minutolo F, Rajabi M, Testai L, Tuccinardi T, Ghidoni R, Macchia M. Bioorg Med Chem. 2010, 18(18):6715-24.
Link to the Journal
49"Protein kinases: docking and homology modeling reliability." Tuccinardi T, Botta M, Giordano A, Martinelli A. J Chem Inf Model. 2010, 50(8):1432-41.
Link to the Journal

Lascia un Commento